Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CAMPTOSAR safely and effectively. See full prescribing information for CAMPTOSAR. CAMPTOSAR® (irinotecan hydrochloride) injection, for intravenous use Initial U.S. Approval: 1996
Medication labelWhy this: Advisory · dailymed-prescription
•CAMPTOSAR is indicated as a component of first-line therapy in combination with 5-fluorouracil (5-FU) and leucovorin (LV) for patients with metastatic carcinoma of the colon or rectum. •CAMPTOSAR is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy.
- generic_name
- irinotecan hydrochloride
- product_names
- irinotecan hydrochloride
- ndc
- 0009-7529, 0009-0112, 0009-0082, 0009-7529-04, 0009-7529-03, 0009-7529-05, 0009-7529-10, 0009-0112-05, 0009-0082-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en